ClaudMcneillGriggJr.MD

PubMed

• Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer.
  Jason Zhu, Chad Livasy, Erin E Donahue, James T Symanowski, Claud M Grigg, Landon C Brown, Justin T Matulay, James T Kearns, Derek Raghavan, Earle F Burgess, Peter E C...> ;Translational Andrology and Urology. 2023 Feb 28
• 3 citations
  Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancer.
  Earle F Burgess, Chad Livasy, Sally Trufan, Jason Zhu, Hazel F O'Connor, Aaron Hartman, Peter E Clark, Claud Grigg, Derek Raghavan> ;Molecular and Clinical Oncology. 2022 May 1
• 3 citations
  Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients
  J. Alexa Sanders, Connor Frasier, Justin T. Matulay, Nury Steuerwald, Jason Zhu, Claud Grigg, James T. Kearns, Stephen B. Riggs, Kris E. Gaston, Cory Brouwer, R. Tucke...> ;Translational Andrology and Urology. 2021 Jul 1
• 6 citations
  Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study
  Caroline Lu, Oluwaseun Adeyemi, William E. Anderson, Timothy Hetherington, David C. Slawson, Hazel Tapp, Tara Eaton, Earle F. Burgess, Claud Grigg, Jason Zhu, Kris E. ...> ;The Journal of Urology. 2021 Apr 1
• 5 citations
  Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumora...
  Claud Grigg, Chad A. Livasy, Jiaxian He, Aaron Hartman, Peter E. Clark, Jason Zhu, Derek Raghavan, Earle F. Burgess> ;Human Pathology. 2021 Jan 1
• 317 citations
  Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
  Catherine A. Shu, Justin F. Gainor, Mark M. Awad, Codruta Chiuzan, Claud Grigg, Aliyah Pabani, Robert Garofano, Mark B. Stoopler, Simon K. Cheng, Abby White, Michael L...> ;The Lancet. Oncology. 2020 Jun 1
• 3 citations
  High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy
  Earle F. Burgess, Chad A. Livasy, Sally Trufan, Aaron Hartman, Renato Guerreri, Caroline Naso, Peter E. Clark, Claud Grigg, James T. Symanowski, Derek Raghavan> ;Urologic Oncology. 2019 Oct 6
• 27 citations
  Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesions.
  Earle F. Burgess, Chad A. Livasy, Aaron Hartman, Myra M. Robinson, James T. Symanowski, Caroline Naso, Shannon E. Doherty, Renato Guerrieri, Stephen B. Riggs, Claud Gr...> ;Urologic Oncology. 2019 May 1
• 684 citations
  Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
  Diego Chowell, Luc G. T. Morris, Claud Grigg, Jeffrey K. Weber, Robert M. Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M. Kendall, David Requena, Nadeem Riaz, ...> ;Science. 2018 Feb 2
• 41 citations
  Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers.
  Claud Grigg, Zoe Blake, Robyn D. Gartrell, Adrian G. Sacher, Bret Taback, Yvonne M. Saenger> ;Seminars in Oncology. 2016 Dec 1
• 151 citations
  PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
  Claud Grigg, Naiyer A. Rizvi> ;Journal for Immunotherapy of Cancer. 2016 Aug 16
• Join now to see all